249 related articles for article (PubMed ID: 27020090)
1. How I treat MDS and AML in Fanconi anemia.
Peffault de Latour R; Soulier J
Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
[TBL] [Abstract][Full Text] [Related]
2. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis.
Yabe M; Morio T; Tabuchi K; Tomizawa D; Hasegawa D; Ishida H; Yoshida N; Koike T; Takahashi Y; Koh K; Okamoto Y; Sano H; Kato K; Kanda Y; Goto H; Takita J; Miyamura T; Noguchi M; Kato K; Hashii Y; Astuta Y; Yabe H
Int J Hematol; 2021 Jan; 113(1):134-144. PubMed ID: 32949371
[TBL] [Abstract][Full Text] [Related]
4. Fanconi anemia.
Soulier J
Hematology Am Soc Hematol Educ Program; 2011; 2011():492-7. PubMed ID: 22160080
[TBL] [Abstract][Full Text] [Related]
5. Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
Yabe M; Koike T; Ohtsubo K; Imai E; Morimoto T; Takakura H; Koh K; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Mori M; Hira A; Takata M; Yabe H
Ann Hematol; 2019 Feb; 98(2):271-280. PubMed ID: 30368588
[TBL] [Abstract][Full Text] [Related]
6. Azacitidine as a bridge to allogeneic hematopoietic cell transplantation in a pediatric patient with Fanconi anemia and acute myeloid leukemia.
Ding H; Hashem H; Cabral L; Rangarajan H; Abusin G; Lazarus HM; Abu-Arja R
Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 27976488
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.
Ayas M; Saber W; Davies SM; Harris RE; Hale GA; Socie G; LeRademacher J; Thakar M; Deeg HJ; Al-Seraihy A; Battiwalla M; Camitta BM; Olsson R; Bajwa RS; Bonfim CM; Pasquini R; Macmillan ML; George B; Copelan EA; Wirk B; Al Jefri A; Fasth AL; Guinan EC; Horn BN; Lewis VA; Slavin S; Stepensky P; Bierings M; Gale RP
J Clin Oncol; 2013 May; 31(13):1669-76. PubMed ID: 23547077
[TBL] [Abstract][Full Text] [Related]
8. T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.
Satty AM; Klein E; Mauguen A; Kunvarjee B; Boelens JJ; Cancio M; Curran KJ; Kernan NA; Prockop SE; Scaradavou A; Spitzer B; Tamari R; Ruggiero J; Torok-Castanza J; Mehta PA; O'Reilly RJ; Boulad F
Bone Marrow Transplant; 2024 Jan; 59(1):23-33. PubMed ID: 37773270
[TBL] [Abstract][Full Text] [Related]
9. An uncommon t(9;11)(p24;q22) with monoallelic loss of
Lovatel VL; de Souza DC; Alvarenga TF; Capela de Matos RR; Diniz C; Schramm MT; Llerena Júnior JC; Silva MLM; Abdelhay E; de Souza Fernandez T
Mol Cytogenet; 2018; 11():40. PubMed ID: 30008805
[TBL] [Abstract][Full Text] [Related]
10. Modern management of Fanconi anemia.
Dufour C; Pierri F
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):649-657. PubMed ID: 36485157
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
[TBL] [Abstract][Full Text] [Related]
12. Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.
Talbot A; Peffault de Latour R; Raffoux E; Buchbinder N; Vigouroux S; Milpied N; Leblanc T; Soulier J; Michallet M; Socié G
Haematologica; 2014 Oct; 99(10):e199-200. PubMed ID: 25085358
[No Abstract] [Full Text] [Related]
13. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
Mehta PA; Davies SM; Leemhuis T; Myers K; Kernan NA; Prockop SE; Scaradavou A; O'Reilly RJ; Williams DA; Lehmann L; Guinan E; Margolis D; Baker KS; Lane A; Boulad F
Blood; 2017 Apr; 129(16):2308-2315. PubMed ID: 28179273
[TBL] [Abstract][Full Text] [Related]
14. Sequential reduced-intensity chemotherapy for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia with rare cytogenetic abnormalities transformed from Fanconi anemia.
Inoue A; Mori A; Yamazaki S; Suzuki R; Takitani K; Tamai H
Pediatr Int; 2018 Sep; 60(9):893-894. PubMed ID: 30255979
[No Abstract] [Full Text] [Related]
15. Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.
Chao MM; Kuehl JS; Strauss G; Hanenberg H; Schindler D; Neitzel H; Niemeyer C; Baumann I; von Bernuth H; Rascon J; Nagy M; Zimmermann M; Kratz CP; Ebell W
Ann Hematol; 2015 Aug; 94(8):1311-8. PubMed ID: 25862235
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for myeloid malignancy in children with Fanconi anemia.
Mehta PA; Ileri T; Harris RE; Williams DA; Mo J; Smolarek T; Auerbach AD; Kelly P; Davies SM
Pediatr Blood Cancer; 2007 Jun; 48(7):668-72. PubMed ID: 16609946
[TBL] [Abstract][Full Text] [Related]
17. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
Trobaugh-Lotrario AD; Kletzel M; Quinones RR; McGavran L; Proytcheva MA; Hunger SP; Malcolm J; Schissel D; Hild E; Giller RH
Bone Marrow Transplant; 2005 Jan; 35(2):143-9. PubMed ID: 15558042
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience.
Peffault de Latour R; Porcher R; Dalle JH; Aljurf M; Korthof ET; Svahn J; Willemze R; Barrenetxea C; Mialou V; Soulier J; Ayas M; Oneto R; Bacigalupo A; Marsh JC; Peters C; Socie G; Dufour C; ;
Blood; 2013 Dec; 122(26):4279-86. PubMed ID: 24144640
[TBL] [Abstract][Full Text] [Related]
20. Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies.
Uchida N; Matsumoto K; Sakura T; Hidaka M; Miyamoto T; Eto T; Maeda Y; Murayama T; Fujishima N; Yoshimoto G; Morita K; Kishimoto J; Teshima T; Taniguchi S; Yamashita T; Mori SI; Akashi K; Harada M;
Int J Hematol; 2020 Oct; 112(4):510-523. PubMed ID: 32656637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
